(-)-Nonactic acid

Details

Top
Internal ID 9a269842-b184-4e5d-9573-ab7b53daa4b0
Taxonomy Organoheterocyclic compounds > Oxolanes
IUPAC Name (2R)-2-[(2R,5S)-5-[(2S)-2-hydroxypropyl]oxolan-2-yl]propanoic acid
SMILES (Canonical) CC(CC1CCC(O1)C(C)C(=O)O)O
SMILES (Isomeric) C[C@@H](C[C@@H]1CC[C@@H](O1)[C@@H](C)C(=O)O)O
InChI InChI=1S/C10H18O4/c1-6(11)5-8-3-4-9(14-8)7(2)10(12)13/h6-9,11H,3-5H2,1-2H3,(H,12,13)/t6-,7+,8-,9+/m0/s1
InChI Key IVOODSRSVJPWLY-UYXSQOIJSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C10H18O4
Molecular Weight 202.25 g/mol
Exact Mass 202.12050905 g/mol
Topological Polar Surface Area (TPSA) 66.80 Ų
XlogP 0.90
Atomic LogP (AlogP) 1.03
H-Bond Acceptor 3
H-Bond Donor 2
Rotatable Bonds 4

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (-)-Nonactic acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9185 91.85%
Caco-2 - 0.7129 71.29%
Blood Brain Barrier + 0.5500 55.00%
Human oral bioavailability - 0.5429 54.29%
Subcellular localzation Mitochondria 0.6657 66.57%
OATP2B1 inhibitior - 0.8488 84.88%
OATP1B1 inhibitior + 0.9323 93.23%
OATP1B3 inhibitior + 0.9464 94.64%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.8500 85.00%
BSEP inhibitior - 0.9682 96.82%
P-glycoprotein inhibitior - 0.9680 96.80%
P-glycoprotein substrate - 0.9506 95.06%
CYP3A4 substrate - 0.5982 59.82%
CYP2C9 substrate - 0.5759 57.59%
CYP2D6 substrate - 0.8589 85.89%
CYP3A4 inhibition - 0.8051 80.51%
CYP2C9 inhibition - 0.8726 87.26%
CYP2C19 inhibition - 0.8792 87.92%
CYP2D6 inhibition - 0.9398 93.98%
CYP1A2 inhibition - 0.7576 75.76%
CYP2C8 inhibition - 0.9761 97.61%
CYP inhibitory promiscuity - 0.9395 93.95%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.8600 86.00%
Carcinogenicity (trinary) Non-required 0.7174 71.74%
Eye corrosion - 0.8807 88.07%
Eye irritation - 0.8961 89.61%
Skin irritation - 0.6378 63.78%
Skin corrosion - 0.9208 92.08%
Ames mutagenesis - 0.6591 65.91%
Human Ether-a-go-go-Related Gene inhibition - 0.8353 83.53%
Micronuclear - 0.9500 95.00%
Hepatotoxicity - 0.5459 54.59%
skin sensitisation - 0.8745 87.45%
Respiratory toxicity - 0.6556 65.56%
Reproductive toxicity - 0.5414 54.14%
Mitochondrial toxicity - 0.5375 53.75%
Nephrotoxicity + 0.4583 45.83%
Acute Oral Toxicity (c) III 0.6823 68.23%
Estrogen receptor binding - 0.5933 59.33%
Androgen receptor binding - 0.8721 87.21%
Thyroid receptor binding - 0.7285 72.85%
Glucocorticoid receptor binding - 0.6128 61.28%
Aromatase binding - 0.8119 81.19%
PPAR gamma - 0.7439 74.39%
Honey bee toxicity - 0.9787 97.87%
Biodegradation - 0.6750 67.50%
Crustacea aquatic toxicity - 0.8700 87.00%
Fish aquatic toxicity + 0.8252 82.52%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 94.59% 96.09%
CHEMBL2581 P07339 Cathepsin D 90.91% 98.95%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 87.54% 95.89%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 86.67% 85.14%
CHEMBL3130 O00329 PI3-kinase p110-delta subunit 86.47% 96.47%
CHEMBL221 P23219 Cyclooxygenase-1 84.86% 90.17%
CHEMBL4793 Q86TI2 Dipeptidyl peptidase IX 83.37% 96.95%
CHEMBL3359 P21462 Formyl peptide receptor 1 83.35% 93.56%
CHEMBL274 P51681 C-C chemokine receptor type 5 82.71% 98.77%
CHEMBL3060 Q9Y345 Glycine transporter 2 82.30% 99.17%
CHEMBL4685 P14902 Indoleamine 2,3-dioxygenase 80.46% 96.38%
CHEMBL3401 O75469 Pregnane X receptor 80.39% 94.73%
CHEMBL3137262 O60341 LSD1/CoREST complex 80.07% 97.09%

Cross-Links

Top
PubChem 11095678
NPASS NPC159771
LOTUS LTS0052919
wikiData Q77501593